Home FDA labels 3972605f-b081-0289-e063-6294a90ab0e3 Fluocinonide openFDA label record# This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
Brand name Fluocinonide
Generic name FLUOCINONIDE
Manufacturer Sun Pharmaceutical Industries, Inc.
Product type HUMAN PRESCRIPTION DRUG
SPL set ID 5782d791-48fd-4cee-853d-235eb4d04a40
SPL ID 3972605f-b081-0289-e063-6294a90ab0e3
Version 3
Effective date 2025-07-08
Source export date 2026-10-12
Source partition 12
Source file https://download.open.fda.gov/drug/label/drug-label-0012-of-0014.json.zip
Source object key raw/openfda/drug-label/2026-10-12/edd23646015c9adc800cdbe2b778398a2d2b70e90dce5721ef2b191499a0397f/drug-label-0012-of-0014.json.zip
Source manifest SHA-256 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run 20261013T011858Z
Imported at 2026-10-13 02:54:00 Harmonized routes table Harmonized routes TOPICAL
Harmonized identifier links# Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 18 matching rows.
Adverse reactions cross-check# openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 2 matching rows.
adverse reactions ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Hypertrichosis Maceration of the Skin Itching Acneiform Eruptions Secondary Infection Irritation Hypopigmentation Skin Atrophy Dryness Perioral Dermatitis Striae Folliculitis Allergic Contact Dermatitis Miliaria
adverse reactions table <table width="80%" styleCode="Noautorules"><col width="26%" align="left" valign="top"/><col width="37%" align="left" valign="top"/><col width="37%" align="left" valign="top"/><tbody><tr><td>Burning</td><td>Hypertrichosis</td><td>Maceration of the Skin</td></tr><tr><td>Itching</td><td>Acneiform Eruptions</td><td>Secondary Infection</td></tr><tr><td>Irritation</td><td>Hypopigmentation</td><td>Skin Atrophy</td></tr><tr><td>Dryness</td><td>Perioral Dermatitis</td><td>Striae</td></tr><tr><td>Folliculitis</td><td>Allergic Contact Dermatitis</td><td>Miliaria</td></tr></tbody></table>
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.